Surface Plasmon Resonance Biosensor Research Articles

High-throughput BCRP inhibitors screening system based on styrene maleic acid polymer membrane protein stabilization strategy and surface plasmon resonance biosensor

Multidrug resistance (MDR) is a dominant challenge in cancer chemotherapy failure. The over-expression of breast cancer resistance protein (BCRP) in tumorous cells, along with its extensive substrate profile, is a leading cause of tumor MDR. Herein, on the basis of styrene maleic acid (SMA) polymer membrane protein stabilization strategy and surface plasmon resonance (SPR) biosensor, a novel high-throughput screening (HTS) system for BCRP inhibitors has been established. Firstly, LLC-PK1 and LLC-PK1/BCRP cell membranes were co-incubated with SMA polymers to construct SMA lipid particles (SMALPs). PK1-SMALPs were thus immobilized in channel 1 of the L1 chip as the reference channel, and BCRP-SMALPs were immobilized in channel 2 as the detection channel to establish the BCRP-SMALPs-SPR screening system. The methodological investigation demonstrated that the screening system was highly specific and stable. Three active compounds were screened out from 26 natural products and their affinity constants with BCRP were determined. The KD of xanthotoxin, bergapten, and naringenin were 5.14 μM, 4.57 μM, and 3.72 μM, respectively. The in vitro cell verification experiments demonstrated that xanthotoxin, bergapten, and naringenin all significantly increased the sensitivity of LLC-PK1/BCRP cells to mitoxantrone with possessing reversal BCRP-mediated MDR activity. Collectively, the developed BCRP-SMALPs-SPR screening system in this study has the advantages of rapidity, efficiency, and specificity, providing a novel strategy for the in-depth screening of BCRP inhibitors with less side effects and higher efficacy.

An investigation of the influence of the graphene layers number on the performance of surface plasmon resonance biosensors with various thicknesses of silver

An investigation of the influence of the graphene layers number on the performance of surface plasmon resonance biosensors with various thicknesses of silver

High sensitive optical fiber SPR sensor for label-free detection of Staphylococcus aureus

Optical fiber bacterial sensors have attracted attention in many fields due to their unique advantages. However, it is still difficult to promote its practicality which is mainly subject to their low sensitivity, inferior stability, and reliability. This work reported here an optical fiber surface plasmon resonance (SPR) biosensor enhanced by gold nanoparticles (AuNPs)/Au film coupling for label-free detection the Staphylococcus aureus (S. aureus), while both the gold substrates were successfully biofunctionalized with goat anti-human immunoglobulin G (IgG) as the probe to capture and detect the bacteria. In the experiment, the refractive index（RI） sensitivity of the Multimode-Singlemode-Multimode optical fiber (MSMOF) coated with Au film was improved by 19 % after the AuNPs were homogeneously decorated on the Au film surface. To detect S. aureus by the sensor, the SPR wavelength variation in the transmission spectrum was recorded, and its limit of detection (LOD) was demonstrated experimentally to be about 50 CFU/mL and was obtained theoretically to be 1.18 CFU/mL during its concentration range of 50–108 CFU/mL. Also, it shows great linearity in the range of 102-108 CFU/mL and the sensor exhibits excellent specificity and stability. This kind of SPR-enhanced optical fiber biosensor is fully promising for its applications in biomedicine, food safety, pharmaceuticals, etc.

An ultra-sensitive biosensor based on surface plasmon resonance and weak value amplification.

An ultra-sensitive phase plasmonic sensor combined with weak value amplification is proposed for the detection of IgG, as a model analyte. Phase detection is accomplished by self-interference between the p-polarization and the s-polarization of the light. With the principles of weak value amplification, a phase compensator is used to modulate the coupling strength and enhance the refractive index sensitivity of the system. On a simple Au-coated prism-coupled surface plasmon resonance (SPR) structure, the scheme, called WMSPR, achieves a refractive index sensitivity of 4.737 × 104 nm/RIU, which is about three times higher than that of the conventional phase-based approach. The proposed WMSPR biosensor gives great characteristics with a high resolution of 6.333 × 10-8 RIU and a low limit of detection (LOD) of 5.3ng/mL. The results yield a great scope to promote the optimization of other SPR biosensors for high sensitivity.

Molybdenum Disulfide‐based Lossy Mode Resonance Sensors: Uncovering Wider Dynamic Range and High Sensitivity Through Computational Approaches

AbstractUntil now, Surface Plasmon Resonance (SPR) biosensors still rely on gold as their transducer element, and this makes cheap analytical devices difficult to achieve. On the other hand, lossy mode resonance (LMR) sensors offer transducers with more alternative materials due to their flexibility, which can be excited in p‐ and s‐polarized light. In this research it is carried out a numerical investigation using the transfer matrix method on LMR sensor composed of molybdenum disulfide (MoS2) as lossy layer and Cytop as matching layer. The reflectance curves for different thicknesses of MoS2 and Cytop are numerically investigated. The results obtained show that the chip consisting of 250 nm Cytop and 4 layers of MoS2 has a penetration depth 3 times higher than conventional SPR chips. If sensors with two types of polarization are compared, sensors with s‐polarized light have shown higher sensitivity reaching 72.13°/RIU with a wider dynamic range starting from a refractive index of 1.331 to 1.401. In this refractive index range, this sensor has displayed good signal stability where the reduction in resonance dip depth is only ≈6%. These computational results make the proposed structure very promising to be applied in the quantification of biological materials.

Recent advance on fiber optic SPR/LSPR-based ultra-sensitive biosensors using novel structures and emerging signal amplification strategies

Biomarkers with ultralow concentration in the actual samples play a vital role in the clinical disease diagnosis, infectious disease screening, food security, and environmental monitoring. Fiber optic (FO)-based surface plasmon resonance (SPR) and localized surface plasmon resonance (LSPR) biosensors attract immense attention for in situ, and rapid detection due to their merits of miniaturized devices, easy integration, and low cost, showing great promising for point of care point-of-caring test. In order to achieve ultrasensitive detection of biomarkers, great effort focused on design of a sensitive FO-based biosensor on the aspect of novel FO probes and signal amplification strategies. Firstly, novel FO probes, including gating and new structure-based, were develop to adjust the light propagation and allow intensely interaction between the light and metal film or nanoparticles, which excites strong SPR or LSPR for sensitive biosensor. Then, nanomaterials on FO surface improved the intensity of electromagnetic fields or provided a good scaffold to modify with more recognition element for signal amplification. Nucleic acid circuits get rid of the limitation of the signal-to-target ratio of 1:1 and exhibited high efficiency to amplify the signal. These efforts have also led to the application of FO-SPR and LSPR sensors for detection of various targets, such as cells, nucleic acids, proteins, and small molecules. In the review, we summarized the important progress of the ultrasensitive FO-based biosensor about emerging FO probes and signal amplification strategies, also discussed its opportunities and challenges for the point-of-caring test. The review aims to promote the application of the FO-SPR and LSPR from experiments to real samples.

A low-temperature SPR-based assay for monoclonal antibody galactosylation and fucosylation assessment using FcγRIIA/B.

Monoclonal antibodies (MAbs) are powerful therapeutic tools in modern medicine and represent a rapidly expanding multibillion USD market. While bioprocesses are generally well understood and optimized for MAbs, online quality control remains challenging. Notably, N-glycosylation is a critical quality attribute of MAbs as it affects binding to Fcγ receptors (FcγRs), impacting the efficacy and safety of MAbs. Traditional N-glycosylation characterization methods are ill-suited for online monitoring of a bioreactor; in contrast, surface plasmon resonance (SPR) represents a promising avenue, as SPR biosensors can record MAb-FcγR interactions in real-time and without labeling. In this study, we produced five lots of differentially glycosylated Trastuzumab (TZM) and finely characterized their glycosylation profile by HILIC-UPLC chromatography. We then compared the interaction kinetics of these MAb lots with four FcγRs including FcγRIIA and FcγRIIB at 5°C and 25°C. When interacting with FcγRIIA/B at low temperature, the differentially glycosylated MAb lots exhibited distinct kinetic behaviors, contrary to room-temperature experiments. Galactosylated TZM (1) and core fucosylated TZM (2) could be discriminated and even quantified using an analytical technique based on the area under the curve of the signal recorded during the dissociation phase of a SPR sensorgram describing the interaction with FcγRIIA (1) or FcγRII2B (2). Because of the rapidity of the proposed method (<5 min per measurement) and the small sample concentration it requires (as low as 30 nM, exact concentration not required), it could be a valuable process analytical technology for MAb glycosylation monitoring.

Surface Plasmon Resonance Biosensors: A Review of Molecular Imaging with High Spatial Resolution.

Surface plasmon resonance (SPR) is a powerful tool for determining molecular interactions quantitatively. SPR imaging (SPRi) further improves the throughput of SPR technology and provides the spatially resolved capability for observing the molecular interaction dynamics in detail. SPRi is becoming more and more popular in biological and chemical sensing and imaging. However, SPRi suffers from low spatial resolution due to the imperfect optical components and delocalized features of propagating surface plasmonic waves along the surface. Diverse kinds of approaches have been developed to improve the spatial resolution of SPRi, which have enormously impelled the development of the methodology and further extended its possible applications. In this minireview, we introduce the mechanisms for building a high-spatial-resolution SPRi system and present its experimental schemes from prism-coupled SPRi and SPR microscopy (SPRM) to surface plasmonic scattering microscopy (SPSM); summarize its exciting applications, including molecular interaction analysis, molecular imaging and profiling, tracking of single entities, and analysis of single cells; and discuss its challenges in recent decade as well as the promising future.

Numerical investigation into impact of halide perovskite material on the optical performance of prism-loaded hybrid surface plasmon resonance biosensor: A strategy to increase sensitivity

The technology of surface plasmon resonance (SPR) is widely recognized and valued for its ability to rapidly and sensitively investigate biomolecular interactivities in real-time. Herein, we numerically investigate the collective influence of metal/ transition metal dichalcogenide (TMDC)/halide perovskite (HP)/2D carbon (C) and phosphorus (P) allotropes on the functionality of an SPR biosensor deploying Kretschmann configuration. The incident light wavelength is held constant at 633 nm, and radiative properties of the hybrid structure are determined using the attenuated total reflection and transfer matrix techniques. Crucial performance metrics such as quality factor (QF), figure of merit (FoM), sensitivity, and detection accuracy are calculated. The comparison is conducted and evaluated against the current literature using performance outcomes in terms of several prisms such as BK7, BAK1, BAF10, SF5, SF10, SF11, 2S2G, CaF2, and CsF, several TMDCs such as WS2, MoS2, WSe2, MoSe2, and PtSe2, several HPs such as CsPbI3, KSnI3, CsSnI3, and FASnI3, and 2D C/P allotropes such as Graphene, MXene, Black phosphorene (BP), and Blue phosphorene (BlueP) in order to search optimum parameters, and then we implement the best one in each layer of this biosensor design. It is noticed that the SPR heterostructure based on BAK1 prism, plasmonic metal Ag, tungsten disulfide (WS2) TMDC, formamidinium tin iodide (FASnI3) HP and 2D BP exhibits outstanding performance with regard to sensor performance characteristics. The observed FoM and sensitivity are 48.2/RIU and 402°/RIU, respectively. The investigation of the electric field distribution within this biosensor along the normal to the interface is also conducted using the finite difference time domain (FDTD) approach to demonstrate the unique contribution of FASnI3. The findings presented in this study are anticipated to play a key role in the improvement of plasmonic resonance-based biosensing domains like DNA hybridization or formalin detection by employing halide perovskite as an additional layer in SPR biosensors.

Highly sensitive photonic crystal fiber based surface plasmon resonance biosensor for detection of wide range of organic solutions

This study introduces a dual-core photonic crystal fiber incorporating a highly responsive plasmonic refractive index (RI) sensor. The performance of the RI sensor is evaluated based on amplitude sensitivity, wavelength resolution, wavelength sensitivity, and the linearity of the resonance wavelength. Employing the finite element technique (FEM), a numerical analysis of the proposed design is conducted. Results indicate that employing the amplitude interrogation method yields a peak amplitude sensitivity of 605.82 RIU−1 for y-polarization. Furthermore, the wavelength interrogation approach for y-polarized modes demonstrates a maximum wavelength sensitivity of approximately 17,000 nm/RIU and a maximum wavelength resolution of 5.88 × 10−6 RIU. The proposed sensor exhibits a figure of merit of approximately 298 and effectively responds to refractive index variations within the range of 1.28 to 1.40. These promising outcomes, coupled with the broad sensing range, establish the suggested sensor as a promising candidate for the detection of organic chemical solutions.

Ultrasensitive Quantification of MUC16 Antigen/Amine-Terminated Aptamer Interaction by Surface Plasmon Resonance: Kinetic and Thermodynamic Studies.

MUC16 is a commonly employed biomarker to identify and predict ovarian cancer (OC). Precise measurement of MUC16 levels is essential for the accurate diagnosis, prediction, and management of OC. This research seeks to introduce a new surface plasmon resonance (SPR) biosensor design that utilizes aptamer-based technology to enable the sensitive and real-time detection of MUC16. In this study, the sensor chip was immobilized with an anti-MUC16 aptamer (Ap) by utilizing 11-mercaptoundecanoic acid (MUA) as a linker to attach the amine-terminated Ap to the chip using EDC/NHS chemistry. The results indicated that the newly created aptasensor had a detection limit of 0.03 U/mL for MUC16 concentration, with a linear range of 0.09 to 0.27 U/mL. The findings demonstrate good precision and accuracy (<15%) for each MUC16 concentration, with recoveries ranging from 93% to 96%. Additionally, the aptasensor exhibited high selectivity, good repeatability, stability, and applicability in real human serum samples, indicating its potential as a valuable tool for the diagnosis and treatment of OC. According to the outcomes, the designed aptasensor exhibited acceptable specificity to detect the CA125 antigen and could be utilized for the serum detection of target antigen by SPR method.

Label-free and early detection of HER2 breast cancer biomarker based on UiO-66-NH2 modified gold chip (Au/UiO-66-NH2) using surface plasmon resonance technique

Breast cancer is one of the leading causes of cancer death for women worldwide. This cancer occurs when the breast cells grow abnormally and spread uncontrolled. Although there are several treatments, including chemotherapy, radiation, and surgery in a clinical setting to cure cancer, these treatments cannot provide a 100 % success rate in eliminating cancer, mainly due to the late diagnosis of the disease. Thus, early detection is the key to provide better breast cancer treatment and a higher chance for survival. Herein, simple and sensitive biosensor by combining the emerging multifunctional materials of metal-organic frameworks (MOFs) with a label-free surface plasmon resonance (SPR) instrument was developed. Two types of stable Zirconium (Zr)-based MOFs, namely Zr benzene dicarboxylic acid (Zr-BDC or UiO-66) and Zr 2-amino-benzene dicarboxylic acid (Zr-BDC-NH2 or UiO-66-NH2) were synthesized using the solvothermal method. X-ray diffractometer (XRD) and fourier transform infra red (FTIR) confirmed the formation of the prepared UiO-66 and UiO-66-NH2. The electron microscopy and nitrogen adsorption desorption isotherm characterization reveal that the MOFs have a cubic crystal structure with a high surface area of 672.4 m2/g for UiO-66 and 286.1 m2/g for UiO-66-NH2. The MOFs are then functionalized on the SPR gold (Au) chip surface to serve as a matrix of Human Epidermal Growth Factor Receptor 2(HER2) antibody receptors. Interestingly, the functionalized SPR biosensors could detect the HER2 protein target with high sensitivity in the ng/mL range and a remarkable detection limit, which is 0.457 ng/mL for UiO-66-NH2. This LOD value is significantly lower than clinical concentrations of HER2 proteins in human blood (∼15 ng/mL), which indicate that the biosensor can offer the capability of early detection test.

Dual BaTiO3 layer-cavity assisted enhancement of copper-based surface plasmon resonance biosensor

Studies have shown that the two-dimensional transition metal dichalcogenides, graphene and MXene (Ti3C2Tx), and other materials not only can effectively improve the sensitivity of the surface plasmon resonance (SPR) biosensor but also reduce the detection accuracy. A SPR sensor based on dual barium titanate (BaTiO3) layers forming Fabry-Pérot (F-P) cavity was proposed to achieve this goal. Specifically, we employed a copper/nickel (Cu/Ni) bimetal as the plasmonic metal, two layers of BaTiO3 wrapped Cu/Ni bimetal to form a F-P cavity structure, and PMMA as the sensing layer. By optimizing the thickness of each film layer, the sensitivity reached 554.6 º/RIU, 6.2% higher than Cu/Ni/PMMA structure, and the corresponding full width at half maximum (FWHM) decreased by 15.4%. In addition, we used seven two-dimensional materials to replace PMMA but keeping other parameters unchanged, the obtained FWHM of the reflection spectrum was also reduced. These findings may benefit the application of the Fabry-Pérot cavity in biosensors and spectral modulation.

Preventing SARS-CoV-2 infection using Fv-antibodies targeting the proprotein convertase (PPC) cleavage site.

Fv-antibodies targeting the proprotein convertase (PPC) region of the SARS-CoV-2 spike protein (SP) were screened from an Fv-antibody library to inhibit SARS-CoV-2 infection. Two selected Fv-antibodies were expressed as soluble recombinant proteins, and their binding affinities were assessed using a surface plasmon resonance biosensor. The binding regions of these Fv-antibodies corresponded to the cleavage sites of furin (S1/S2) and transmembrane serine protease 2 (TMPRSS2, S2'). The neutralizing activities of the two Fv-antibodies were demonstrated using a cell-based infection assay with pseudo-viruses carrying the SP of four different SARS-CoV-2 variants: wild-type (D614), delta (B.1.617.2), omicron (BA.2), and omicron (BA.4/5).

Adenosine Detection in Serum using a Surface Plasmon Resonance Biosensor with Molecularly Imprinted Polymers incorporating Modified Thymidine Monomers

Stress is a response to stimuli which disrupt the homeostasis of a cell or organism. Adenosine is a purine nucleoside which functions as an immunomodulator and signaling molecule, with elevated...

Development of therapeutic monoclonal antibodies against DKK1 peptide-HLA-A2 complex to treat human cancers

BackgroundTargeted immunotherapy with monoclonal antibodies (mAbs) is an effective and safe method for the treatment of malignancies. Development of mAbs with improved cytotoxicity, targeting new and known tumor-associated antigens, therefore...

Silver-coated hollow fiber surface plasmon resonance sensor for glucose detection with enhanced limit of detection.

A fiber-optic surface plasmon resonance (SPR) biosensor based on a silver-coated hollow fiber (HF) structure for glucose detection is presented. The sensor surface was immobilized with 4-mercaptophenylboronic acid (PMBA) acting as a glucose recognition monolayer. Then, gold nanoparticles (AuNPs) modified with 2-aminoethanethiol (2-AET) and PMBA were introduced onto the sensor surface after glucose was captured to enhance the wavelength shift of the SPR phenomenon excited by the light transmitted in the wall of the HF sensor. Instead of the conventional one-step sensitization pretreatment commonly used in the deposition process of silver films for fiber-optic SPR sensors, a sensitization-activation two-step activation method was adopted in the fabrication of the proposed sensor. Experiments for glucose detection were performed on the fabricated sensors in the concentration range of 1 nM-1 mM. Results showed that the sensor fabricated by the two-step activation method has a much larger shift of resonance wavelength than the sensor fabricated using the one-step sensitization method. The resonance wavelength shift was found to be linear to the logarithm of the concentration in the range of 1 nM-1 mM. The sensor achieved a limit of detection (LOD) of as low as 1 nM, which is at least an order of magnitude lower than that of other fiber-optic sensors for glucose detection reported previously. The presented HF glucose sensor has the potential for biosensing applications and provides a large reference value in the study of optical fiber SPR sensors for biosensing.

Multi-layer SPR biosensor for in-Situ Amplified monitoring of the SARS-CoV-2 omicron (B.1.1.529) variant

This article represents an analysis of the performance of multi-layer surface plasmon resonance (SPR) biosensors in detecting the transferable human SARS-CoV-2 Omicron (B.1.1.529) variant. The proposed multi-layer SPR biosensor performance is enhanced by integrating fine-tuning prisms, plasmonic metals, and two-dimensional (2D) transition metal dichalcogenides (TMDs) materials. To evaluate the performance of the multi-layer SPR sensor, the transfer matrix method (TMM) is employed. In numerical result, the proposed (CaF2/Cu/BP/Graphene) structure demonstrates the most favorable sensitivity and detection accuracy, characterized by a 410° angle shift sensitivity/refractive index unit (RIU). Additionally, the sensor achieves a detection accuracy (DA) of 0.4713, a quality factor (QF) of 94.25 RIU−1, a figure of merit (FOM) of 91.87, and a combined sensitivity factor (CSF) of 90.36. The presented sensor is also capable of detecting target biomolecule binding interactions between ligands and analytes at a range of concentrations (from 0 nM to 1000 nM), implying its potential use for detecting the omicron virus strain. The outcomes highlight the effectiveness of the presented sensor for real time, and label free detection, particularly in identifying the Omicron viral strain. Eventually, this research promises advanced biosensor technology, crucial for rapid viral variant detection and diagnostics.

Optimizing Plasmonic Microarray Biosensors: Custom Optical System for Enhanced Evaluation and Characterization

This paper presents the design and implementation of a tailored optical system for rapid characterization of transmission-based localized surface plasmon resonance (LSPR) biosensors. The system incorporates a motorized monochromator, offering extreme versatility in experimenting with wavelength resolution and bandwidth of the illumination. This setup streamlines the process of determining optimal chip design parameters such as the density of nanoparticles and the number of detection wavelengths required, as measurements are fully automated and software-driven. Furthermore, the system facilitates straightforward detection of manufacturing errors, including misaligned spots or inhomogeneous particle distribution, enhancing overall efficiency and reliability in biosensor evaluation.

PCF-based Sensors for Biomedical Applications-A Review.

The article provides a comprehensive overview of the current and future advances of Photonic crystal fiber (PCF) based biosensors, the research explores the impact of structural parameter variations on phase matching conditions, by investigating pitch, air hole diameter, and gold layer thickness. Currently, these surface plasmon resonance (SPR) biosensors demonstrate the ability to detect a range of biological substances such as glucose, pH, serum proteins, and similar chemicals. They have the capacity to directly identify bio-components in urine, blood, and saliva, as well as pathogens, bacteria, and contaminants in food, water, and air. The study investigates by presenting the fundamental principles of PCF biosensors, highlighting their comparative benefits over conventional biosensors. Recent studies utilizing PCF biosensors for various application are reviewed, the findings of the review suggest that the integration of SPR enhances the sensing capabilities of these biosensors, making them promising tools for diverse applications in the field of biosensing.